Literature DB >> 15091311

Genetic studies of neuropsychiatric disorders in Costa Rica: a model for the use of isolated populations.

Carol A Mathews1, Victor I Reus, Julio Bejarano, Michael A Escamilla, Eduardo Fournier, Luis Diego Herrera, Thomas L Lowe, L Alison McInnes, Julio Molina, Roel A Ophoff, Henrietta Raventos, Lodewijk A Sandkuijl, Susan K Service, Mitzi Spesny, Pedro E León, Nelson B Freimer.   

Abstract

The importance of genetics in understanding the etiology of mental illness has become increasingly clear in recent years, as more evidence has mounted that almost all neuropsychiatric disorders have a genetic component. It has also become clear, however, that these disorders are etiologically complex, and multiple genetic and environmental factors contribute to their makeup. So far, traditional linkage mapping studies have not definitively identified specific disease genes for neuropsychiatric disorders, although some potential candidates have been identified via these methods (e.g. the dysbindin gene in schizophrenia; Straub et al., 2002; Schwab et al., 2003). For this reason, alternative approaches are being attempted, including studies in genetically isolated populations. Because isolated populations have a high degree of genetic homogeneity, their use may simplify the process of identifying disease genes in disorders where multiple genes may play a role. Several areas of Latin America contain genetically isolated populations that are well suited for the study of neuropsychiatric disorders. Genetic studies of several major psychiatric illnesses, including bipolar disorder, major depression, schizophrenia, Tourette Syndrome, alcohol dependence, attention deficit hyperactivity disorder, and obsessive-compulsive disorder, are currently underway in these regions. In this paper we highlight the studies currently being conducted by our groups in the Central Valley of Costa Rica to illustrate the potential advantages of this population for genetic studies.

Entities:  

Mesh:

Year:  2004        PMID: 15091311     DOI: 10.1097/00041444-200403000-00003

Source DB:  PubMed          Journal:  Psychiatr Genet        ISSN: 0955-8829            Impact factor:   2.458


  14 in total

1.  Neuropsychological and dimensional behavioral trait profiles in Costa Rican ADHD sib pairs: Potential intermediate phenotypes for genetic studies.

Authors:  Viviana A Peskin; Anna Ordóñez; R Scott Mackin; Kevin Delucchi; Silvia Monge; James J McGough; Denise A Chavira; Monica Berrocal; Erika Cheung; Eduardo Fournier; Judith A Badner; Luis Diego Herrera; Carol A Mathews
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2015-03-31       Impact factor: 3.568

2.  [Prevalence of and screening for ADHD in Costa Rica].

Authors:  Mónica Berrocal; Viviana Peskin; Nicholas Weiss; Jovita Schuler; Silvia Monge; James J McGough; Denise Chavira; Mónica Bagnarello; Luis D Herrera; Carol A Mathews
Journal:  Vertex       Date:  2011 Sep-Oct

3.  Lack of association to a NRG1 missense polymorphism in schizophrenia or bipolar disorder in a Costa Rican population.

Authors:  Emily Moon; Brandi Rollins; Andrea Mesén; Adolfo Sequeira; Richard M Myers; Huda Akil; Stanley J Watson; Jack Barchas; Edward G Jones; Alan Schatzberg; William E Bunney; Lynn E DeLisi; William Byerley; Marquis P Vawter
Journal:  Schizophr Res       Date:  2011-07-13       Impact factor: 4.939

4.  Heritability of cognitive functions in families of successful cognitive aging probands from the Central Valley of Costa Rica.

Authors:  Tiffany A Greenwood; Michal S Beeri; James Schmeidler; Daniel Valerio; Henriette Raventós; Lara Mora-Villalobos; Karla Camacho; José R Carrión-Baralt; Gary Angelo; Laura Almasy; Mary Sano; Jeremy M Silverman
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

5.  Genomewide linkage analysis in Costa Rican families implicates chromosome 15q14 as a candidate region for OCD.

Authors:  Jessica Ross; Judith Badner; Helena Garrido; Brooke Sheppard; Denise A Chavira; Marco Grados; Jonathan M Woo; Pamela Doo; Paula Umaña; Eduardo Fournier; Sarah Shaw Murray; Carol A Mathews
Journal:  Hum Genet       Date:  2011-06-21       Impact factor: 4.132

6.  Characteristics and comorbidity of ADHD sib pairs in the Central Valley of Costa Rica.

Authors:  Jovita Schuler; Nicholas T Weiss; Denise A Chavira; James J McGough; Monica Berrocal; Brooke Sheppard; Evelyn Vaglio; Eduardo Fournier; Luis Diego Herrera; Carol A Mathews
Journal:  Compr Psychiatry       Date:  2011-06-21       Impact factor: 3.735

7.  Arizona Study of Aging and Neurodegenerative Disorders and Brain and Body Donation Program.

Authors:  Thomas G Beach; Charles H Adler; Lucia I Sue; Geidy Serrano; Holly A Shill; Douglas G Walker; LihFen Lue; Alex E Roher; Brittany N Dugger; Chera Maarouf; Alex C Birdsill; Anthony Intorcia; Megan Saxon-Labelle; Joel Pullen; Alexander Scroggins; Jessica Filon; Sarah Scott; Brittany Hoffman; Angelica Garcia; John N Caviness; Joseph G Hentz; Erika Driver-Dunckley; Sandra A Jacobson; Kathryn J Davis; Christine M Belden; Kathy E Long; Michael Malek-Ahmadi; Jessica J Powell; Lisa D Gale; Lisa R Nicholson; Richard J Caselli; Bryan K Woodruff; Steven Z Rapscak; Geoffrey L Ahern; Jiong Shi; Anna D Burke; Eric M Reiman; Marwan N Sabbagh
Journal:  Neuropathology       Date:  2015-01-26       Impact factor: 1.906

8.  Shared genetic factors influence risk for bipolar disorder and alcohol use disorders.

Authors:  N Carmiol; J M Peralta; L Almasy; J Contreras; A Pacheco; M A Escamilla; E E M Knowles; H Raventós; D C Glahn
Journal:  Eur Psychiatry       Date:  2013-12-08       Impact factor: 5.361

9.  Dysbindin gene (DTNBP1) and schizophrenia in Korean population.

Authors:  Chi-Un Pae; Laura Mandelli; Diana De Ronchi; Jung-Jin Kim; Tae-Youn Jun; Ashwin A Patkar; Alessandro Serretti
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-02-28       Impact factor: 5.270

10.  Identification of novel schizophrenia loci by homozygosity mapping using DNA microarray analysis.

Authors:  Naohiro Kurotaki; Shinya Tasaki; Hiroyuki Mishima; Shinji Ono; Akira Imamura; Taeko Kikuchi; Nao Nishida; Katsushi Tokunaga; Koh-ichiro Yoshiura; Hiroki Ozawa
Journal:  PLoS One       Date:  2011-05-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.